Sch 52900 (1) and Sch 52901 (2), two new inhibitors of c-fos proto-oncogene induction, have been isolated from the fermentation broth of the fungal culture (SCF-1 168), Gliocladium sp. Along with compounds 1 and 2, a known compound verticillin A (3) was also obtained from the culture. Structure elucidation of 1 and 2, accomplished by analysis of spectral data in comparison with the data of 3, revealed both 1 and 2 were found to be closely related to the verticillin family of diketopiperazines. All three compoundsprevented serum-stimulated transcription of the humanc-fos promoter, using afos/lac Z reporter gene assay, with IC50 values of 1.5, 18 and 0.5fM for 1, 2 and 3, respectively. Northern analysis revealed that exposure of cells to compound3 causes inhibition of both phorbol ester-induced c-fos induction and serum-induced JE induction in the absence of inhibiting RNAsynthesis, as measured by [3H]uridine incorporation. These results suggest that this class of compounds exerts antitumor activity by blocking a signal transduction pathway that is commonto and necessary for the induction of at least a subset of immediate early genes involved in cell proliferation.
Intracellular induction of the c-fos proto-oncogene is amongthe earliest events in the transition of cells from a quiescent to a growing state, and is induced by a variety of mitogens, including serum, platelet derived growth factor and epidermal growth factor1~3).
In addition, oncogene expression of v-src, v-raf and Ha-ras has been shown to induce c-fos4~6\ and certain tumor cells have Fig. 1 . The structures of1, 2 and 3. DEC. 1995 been shown to possess constitutively elevated levels of c-fosn). This suggests that inhibitors of c-fos protooncogeneinduction could serve as therapeutic agents for the control of neoplastic disease. Utilizing a fos/Lac Z reporter gene system to identify inhibitors of c-fos proto-oncogene induction from microbial sources, we identified three diketopiperazines, isolated from a fermentation broth of the fungus (culture SCF-1 168), Gliocladium sp., with potent activity to inhibit c-fos proto-oncogene induction. The minor components, Sch 52900 (1) and Sch 52901 (2), were found to be novel compounds closely related to the major component, verticillin A (3), previously identified as an antitumor compound8). In this paper, we report the fermentation, isolation, structure determination and mechanism of antitumor activity of 1, 2, and 3.
Materials and Methods General
The optical rotations were measured on a Rudolph Research model 'AUTOPOLIII' automatic polarimeter.
The melting points were determined on a MEL-TEMP apparatus (Laboratory Devices, Cambridge, MA)and are uncorrected. IR spectra were obtained using a Nicolet FTIR Model 10-MXinstrument. UVspectra were recorded on a Hewlett Packard '8450A' UV-vis spectrophotometer. FAB-massspectra were produced on a of serum, to a final concentration of 20%, directly to the medium. Three hours after serum addition, monolayers were lysed and assayed for jS-galactosidase activity as described below. To normalize for nonspecific toxicity, the ratios of serum-stimulated vs. unstimulated monolayers were determined at each compoundconcentration, and IC50 values were defined as the concentration required to give a stimulated/unstimulated ratio midway between the stimulated/unstimulated controls, and the endpoint ratio of 1 : 1 (stimulated/unstimulated), and were determined by linear regression analysis.
jS-Galactosidase Assays jS-galactosidase activity was measured by a modification of the procedure provided by Pharmacia. Briefly, quiescent monolayers of Clone 68-220 cells were treated with serial 1 : 2 dilutions of testing compound in medium supplemented with 0.5% bovine calf serum. The following day, serum was added to replicate monolayers and cultures were incubated an additional 3 hours at 37°C to permit /?-galactosidase induction. Unstimulated and serum-stimulated monolayers were rinsed twice with phosphate-buffered saline, then lysed in \0 jA of ice-cold lac Z extraction buffer (Z buffer+0.5% NP-40+20% glycerol) for 20minutes on ice. Following lysis, 50//I of a 0.8 mg/ml solution of O-nitrophenyl-/?-D-galactopyranoside dissolved in Z buffer (lOmM KC1 + 1 mMMgSO4+ 50mMmercaptoethanol+O.l M Na2PO4, pH 7.0) was added to each well, and plates were incubated at 37°C
for 4 hours. The reaction was terminated by addition of 30^1 of a freshly made solution of 1 m Na2CO3+0.3% sodium dodecylsulphate, and absorbance at 420nm was measured.
Effects of Compound3 on Gene Induction
In BALB/c3T3 cells, induction of c-fos occurs predominantly through a protein kinase C-mediated pathway12). To evaluate the ability of 3 to block protein kinase C-mediated induction of the endogenous murine
The fungus was supplied by Dr. B. Katz from MYCOsearchLab.
c-fos, quiescent monolayers of 68-220 cells were exposed to 10 and 20nMof 3 for 3 hours. Following treatment, TPA (12-Otetradecanoylphorbol-1 3-acetate) was added directly to the 3-containing medium to a final concentration of 300 nM. Following an additional incubation at 37°C for 1 hour, cells were harvested. Total RNAwas extracted by the method of Keath et al.13 
Structure Elucidation
The structures of 1 and 2 were determined by analysis of spectroscopic data including UV, IR, MS (Table 1) , XH and 13CNMR (Tables 2 and 3) . XH and 13CNMR spectral data indicated that both 1 and 2 belong to the verticillin family by direct comparison to the major differences between the two alkyl methyl (C-CH3) and nitrogenated methyl (N-CH3) carbons for 1 were also observed. The signal of an oxygenated methine carbon at 8 66.8 was assigned as a secondary alcohol at C-13' position. XHNMRdata were consistent with 13C NMRdata, which showed an unsymmetrical dimer. A doublet of group, in the molecule. The remaining proton assignments were comparable to 3. Based on the above evidence, the structure of 1 was proposed as indicated in Figure 1 showing a dimeric structure consisting of two slightly differing monomers.
The molecular weight of2 was established as 710 from FAB-MSthat showed a protonated molecular ion, (M+H)+, at m/z 111. The compound also contained a disulfide moiety which is supported by the mass spectrum (a loss of64 mass units due to S2). The molecular formula was deduced as C31H30N6O6S4 from high resolution FAB-MS (Calcd: 711.1188, measured: 711.1177 for (M+H)+ of C31H31N6O6S4) and NMRspectral data. The UVand IR spectra were very similar to 1, indicating that they are structurally related to each other. As shown in Table 3 , a methylene at 3 24.06 along with a methyl carbon at 3 9.35 displayed an ethyl group at C-13' and C-14' positions. The presence of CH2CH3 group was supported by XHNMRspectrum which showed the ABmultiplets ofmethylene protons at 3 2.30, and the triplet ofmethyl protons at 3 1.26 (/=7.4Hz). The assignments of remaining carbons and protons appeared to be comparable to 1 and a proposed structure of2 is shown in Figure 1 because it showed the most potent inhibitory activity in the fos/lac Z reporter gene assay. Even though 3 has been previously reported as an antitumor agent, the DEC. 1995 mechanismof action remained unknown. To further explore the mechanism of action for verticillin family of compounds, the mechanistic studies of 3 were performed.
Quiescent BALB/c 3T3 cells were stimulated by addition of TPA(300nM final concentration) or serum (20% final concentration). One hour after stimulation, total RNAwas extracted and probed for the induction of c-fos (Fig. 2, A) and JE (Fig. 2, B) , respectively. In the absence of 3, both c-fos and JE were induced greater than 20-fold. Compound 3 inhibited both TPA-mediated induction of c-fos and serum-mediated induction of JE to similar extents at similar concentrations, with significant inhibition occurring at 10 nM, and greater than 80% inhibition occurring at 20nM (Fig. 2, A and B) . To determine whether 3 exerted effects by acting as a general inhibitor of RNAsynthesis, quiescent monolayers of 68~220 cells were exposed to 3 for 3 hours. Then pulse-labeled for 1 hour with [5-3H] In BALB/c 3T3 cells, induction of c-fos occurs predominantly through the protein kinase C pathway12).
This, plus our demonstration that 3 inhibits TPAmediated induction of c-fos, suggests that the cellular target(s) for 3 is involved in protein kinase C-mediated signal transduction.
Northern analysis presented here demonstrates that, similiar to the ability to inhibit the induction of our c-fosIlac Z reporter gene, 3 inhibited TPA-mediated induction of c-fos at concentrations as low as 10 nM, with greater than 80%inhibition occurring at 20 nM concentrations (Fig. 2, A) . In contrast, induction ofJE occurs by a pathway which does not involve protein kinase C13). Compound 3 inhibited serum-mediated induction of the JE gene, at concentrations as low as 20nM (Fig. 2, B) . The experiments demonstrating that 3 did not inhibit [5-3H]uridine incorporation indicated that the mechanism of verticillin-mediated inhibition of gene induction did not involve general transcriptional inhibition.
The ability of 3 to inhibit both protein kinase C-dependent and -independent gene induction suggests that the biological target of 3 is involved in a common signal transduction pathway that is necessary for both protein kinase C-dependent and -independent gene induction. The alternative possibility, that 3 blocks two or more biological targets, is less likely in view of the similar concentration requirements needed to inhibit both c-fos and JE induction. Wesuggest that 3 (verticillin A) exerts its antitumor effects by inhibiting a signal transduction pathway commonto the induction of at least a subset of immediate early genes. Our results indicating that verticillin A inhibits activation of more than one signalling pathway suggest that the compound could be acting at a very early step in the signalling pathway, responsible for activation of multiple signalling pathways leading to c-fos proto-oncogene induction. In suport of this, preliminary results* indicate that at 1 jim, verticillin A inhibits pl85c"neM phosphorylation of poly (glu, tyr) by 20%, suggesting that the compoundcould exert its effects by inhibiting phosphorylation by specific receptor tyrosine kinases. Identification of the verticillin target can be expected to lead to the discovery of a critical enzyme in signal transduction.
